Phase II study of M518101 in patients with verruca vulgaris
Phase 2
Completed
- Conditions
- verruca vulgaris
- Registration Number
- JPRN-jRCT2080223883
- Lead Sponsor
- Maruho Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Patients with verruca vulgaris patients
Exclusion Criteria
1) Patients who have a history or presence of serious drug hyper sensitivity
2) Patients who have cardiac, hepatic, renal, pulmonary, blood disease considered inappropriate for participation in clinical trials
3) Patients with immunosuppression
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method